Thermo Fisher Scientific Inc. (TMO)

Sector: Technology
Industry: Measuring & Controlling Devices, NEC
Country: United States
Exchange: NYSE
Market cap: $255.19B
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
Latest financial period: September 26, 2026
Filed with the SEC: October 30, 2026
Estimated earnings date: Not available
Profit #832 of 1421 companies
| | Sep 26 | Jun 26 | Mar 26 | Dec 25 |
|---|
| ROIC | 8.7% | 8.8% | 8.7% | 9.0% |
Growth #655 of 1421 companies
Payout #43 of 1421 companies
Safety #248 of 1421 companies
Price #1056 of 1421 companies